Blog Archive

Search This Blog

Wednesday, July 19, 2017

A Study of ABBV-181 in Participants With Advanced Solid Tumors

Condition:   Advanced Solid Tumors
Interventions:   Drug: ABBV-181;   Drug: Rovalpituzumab Tesirine
Sponsor:   AbbVie
Recruiting - verified July 2017

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2uaNqo4

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...